Showing results (91-100 of 1,894) with videos related to
Sort By:
Pageof 190
Chemotherapy|January 1, 1992
US experience with itraconazole in Aspergillus, Cryptococcus and Histoplasma infections in the immunocompromised hostJ S Hostetler, D W Denning, D A StevensFolia Microbiologica|September 21, 2000
Use of the 6-methylsalicylic-acid-synthase gene as a discriminating marker between Aspergillus terreus and Aspergillus flavipesS Pazoutová, I Hamplová, M Anderson, et al.International Journal of Antimicrobial Agents|August 26, 1999
Activity of pradimicin BMS-181184 against Aspergillus sppK L Oakley, C B Moore, D W DenningAntimicrobial Agents and Chemotherapy|May 17, 2001
In vitro activities of terbinafine against Aspergillus species in comparison with those of itraconazole and amphotericin BC B Moore, C M Walls, D W DenningEuropean Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|September 1, 1990
In vitro activity of saperconazole (R66 905) compared with amphotericin B and itraconazole against Aspergillus speciesD W Denning, L H Hanson, D A StevensThorax|December 1, 1993
Unilateral wheeze caused by pseudomembranous aspergillus tracheobronchitis in the immunocompromised patientR C Tait, B R O'Driscoll, D W DenningInfection and Immunity|March 1, 1996
Evidence of multiple extracellular phospholipase activities of Aspergillus fumigatusM Birch, G Robson, D Law, et al.Microbiology (Reading, England)|September 1, 1994
Hydrocortisone-enhanced growth of Aspergillus spp.: implications for pathogenesisT T Ng, G D Robson, D W DenningEuropean Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|April 1, 1997
Azole resistance in CandidaD W Denning, G G Baily, S V HoodMedical Mycology|August 23, 2005
The invasive and saprophytic syndromes due to Aspergillus sppW W Hope, T J Walsh, D W DenningPageof 190